By tracing the tissue’s biological response, BioTrace is the only system that can utilize an ultrasound device to visualize tissue viability in real-time and provide a unique damage map that represents the full extent of damage as seen 24hrs post-treatment
TechsoMed Raises $7 Million Series B Financing: Funding to Support Company’s Pursuit of FDA Approval & Commercialization Readiness
Following clinical and regulatory approval, the company's technology has the potential to help physicians ensure treatment accuracy and increase treatment efficacy.